| 2025-12-10 |
详情>>
内部人交易：
Agrawal Rekha等共交易7笔
|
| 2025-12-09 |
详情>>
股本变动：
变动后总股本19554.60万股
|
| 2025-12-09 |
详情>>
业绩披露：
2026年一季报每股收益2.91美元,归母净利润5.70亿美元,同比去年增长21.28%
|
| 2025-12-09 |
财报披露：
美东时间 2025-12-09 盘前发布财报
|
| 2025-10-15 |
股东大会：
将于2025-12-03召开股东大会
会议内容 ▼▲
- 1.To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company’s next annual meeting of stockholders and until such Director’s successor shall have been elected and qualified.
2.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the transition period from August 1, 2025 to December 31, 2025.
3.To approve, on an advisory basis, the fiscal 2025 compensation of the Company’s Named Executive Officers.
4.Transact such other business as may properly come before the 2025 Annual Meeting or any adjournment or postponement thereof.
|
| 2025-10-15 |
股东大会：
将于2025-12-03召开股东大会
会议内容 ▼▲
- 1.To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company’s next annual meeting of stockholders and until such Director’s successor shall have been elected and qualified.
2.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the transition period from August 1, 2025 to December 31, 2025.
3.To approve, on an advisory basis, the fiscal 2025 compensation of the Company’s Named Executive Officers.
4.Transact such other business as may properly come before the 2025 Annual Meeting or any adjournment or postponement thereof.
|
| 2025-09-26 |
详情>>
业绩披露：
2025年年报每股收益9.33美元,归母净利润18.56亿美元,同比去年增长6.97%
|
| 2025-09-26 |
详情>>
业绩披露：
2023年年报每股收益9.15美元,归母净利润18.89亿美元,同比去年增长-10.98%
|
| 2025-06-03 |
详情>>
业绩披露：
2025年三季报(累计)每股收益5.79美元,归母净利润11.56亿美元,同比去年增长-9.97%
|
| 2025-03-11 |
详情>>
业绩披露：
2025年中报每股收益3.73美元,归母净利润7.46亿美元,同比去年增长-11.3%
|
| 2024-12-10 |
详情>>
业绩披露：
2025年一季报每股收益2.34美元,归母净利润4.70亿美元,同比去年增长-9.44%
|
| 2024-10-15 |
股东大会：
将于2024-12-05召开股东大会
会议内容 ▼▲
- 1.To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company’s next annual meeting and until such Director’s successor shall have been elected and qualified
2.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal 2025
3.To approve, on an advisory basis, the fiscal 2024 compensation of the Company’s Named Executive Officers
4.To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Company’s Named Executive Officers
|
| 2024-10-15 |
股东大会：
将于2024-12-05召开股东大会
会议内容 ▼▲
- 1.To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company’s next annual meeting and until such Director’s successor shall have been elected and qualified
2.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal 2025
3.To approve, on an advisory basis, the fiscal 2024 compensation of the Company’s Named Executive Officers
4.To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Company’s Named Executive Officers
|
| 2024-09-25 |
详情>>
业绩披露：
2024年年报每股收益8.55美元,归母净利润17.35亿美元,同比去年增长-8.15%
|
| 2024-09-25 |
详情>>
业绩披露：
2022年年报每股收益9.75美元,归母净利润21.22亿美元,同比去年增长44.16%
|
| 2024-06-05 |
详情>>
业绩披露：
2024年三季报(累计)每股收益6.32美元,归母净利润12.84亿美元,同比去年增长-1.61%
|
| 2024-04-18 |
股东大会：
将于2024-05-30召开股东大会
会议内容 ▼▲
- 1.A proposal to approve the Merger Agreement, a copy of which is attached to this proxy statement/prospectus as Annex A, and approve the transactions contemplated thereby. Your approval of the Merger Proposal will constitute your approval of the Merger Agreement and the transactions contemplated thereby, including the Merger. See the section entitled “Proposal No. 1—The Merger Proposal.”
2.Eight separate Proposals, on an advisory basis, with respect to certain differences between the Ferguson Governing Documents and New TopCo Proposed Organizational Documents (each to be effective upon the Merger), which are being presented separately in accordance with SEC guidance to give Ferguson Shareholders the opportunity to present their views on important corporate governance provisions. See the section entitled “Proposal No. 2—The Advisory Organizational Documents Proposals.”
|
| 2024-04-18 |
股东大会：
将于2024-05-30召开股东大会
会议内容 ▼▲
- 1.A proposal to approve the Merger Agreement, a copy of which is attached to this proxy statement/prospectus as Annex A, and approve the transactions contemplated thereby. Your approval of the Merger Proposal will constitute your approval of the Merger Agreement and the transactions contemplated thereby, including the Merger. See the section entitled “Proposal No. 1—The Merger Proposal.”
2.Eight separate Proposals, on an advisory basis, with respect to certain differences between the Ferguson Governing Documents and New TopCo Proposed Organizational Documents (each to be effective upon the Merger), which are being presented separately in accordance with SEC guidance to give Ferguson Shareholders the opportunity to present their views on important corporate governance provisions. See the section entitled “Proposal No. 2—The Advisory Organizational Documents Proposals.”
|
| 2024-03-06 |
详情>>
业绩披露：
2024年中报每股收益4.13美元,归母净利润8.41亿美元,同比去年增长-13.21%
|
| 2023-12-06 |
详情>>
业绩披露：
2024年一季报每股收益2.55美元,归母净利润5.19亿美元,同比去年增长-12.77%
|
| 2023-10-17 |
股东大会：
将于2023-11-28召开股东大会
会议内容 ▼▲
- 1.To elect each of the 11 Director nominees named in the Proxy Statement for a term expiring at the next Annual General Meeting of the Company.
2.To reappoint Deloitte LLP as the Company’s statutory auditor under the Companies (Jersey) Law 1991 until the conclusion of the next Annual General Meeting of the Company.
3.To authorize the Audit Committee on behalf of the Board to agree to the compensation of the Company’s statutory auditor under the Companies (Jersey) Law 1991.
4.To receive the Company’s Annual Accounts and Auditors’ Report for the fiscal year ended July 31, 2023.
5.To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement for the 2023 Annual General Meeting under the heading “Executive Compensation,” including the Compensation Discussion and Analysis, the compensation tables and the related narrative discussion included therein (“Say-on-Pay”).
6.To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Company’s Named Executive Officers (“Say-on-Frequency”).
7.To approve the Ferguson plc 2023 Omnibus Equity Incentive Plan.
8.To renew the power conferred on the Board pursuant to Article 12 of the articles of association of the Company (the “Articles”) or the articles of association produced to the 2023 Annual General Meeting as the new articles of association of the Company (the “New Articles”) (as applicable) to allot or sell Equity Securities (as defined in the Articles or the New Articles (as applicable)), and for that purpose, the Authorized Allotment Amount (as defined in the Articles or the New Articles (as applicable)) shall be an aggregate nominal amount of up to ￡6,799,457 and in addition the Authorized Allotment Amount shall be increased by an aggregate nominal amount of up to ￡6,799,457 provided that the Board’s power in respect of such latter amount may only be used in connection with a pre-emptive issue (as defined in the Articles or the New Articles (as applicable)). This authority shall, unless previously revoked or varied, expire at the conclusion of the Company’s next Annual General Meeting (or, if earlier, at the close of business on the date which is 15 months after the date of the passing of this Resolution) save that the Board may, before such expiry, make offers or agreements (whether or not conditional) within the terms of this authority which would or might require Equity Securities to be allotted or sold after such expiry, and the Board may allot or sell Equity Securities pursuant to such offers or agreements as if the authority conferred on them hereby had not expired.
|
| 2023-10-17 |
股东大会：
将于2023-11-28召开股东大会
会议内容 ▼▲
- 1.To elect each of the 11 Director nominees named in the Proxy Statement for a term expiring at the next Annual General Meeting of the Company.
2.To reappoint Deloitte LLP as the Company’s statutory auditor under the Companies (Jersey) Law 1991 until the conclusion of the next Annual General Meeting of the Company.
3.To authorize the Audit Committee on behalf of the Board to agree to the compensation of the Company’s statutory auditor under the Companies (Jersey) Law 1991.
4.To receive the Company’s Annual Accounts and Auditors’ Report for the fiscal year ended July 31, 2023.
5.To approve, on an advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Proxy Statement for the 2023 Annual General Meeting under the heading “Executive Compensation,” including the Compensation Discussion and Analysis, the compensation tables and the related narrative discussion included therein (“Say-on-Pay”).
6.To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Company’s Named Executive Officers (“Say-on-Frequency”).
7.To approve the Ferguson plc 2023 Omnibus Equity Incentive Plan.
8.To renew the power conferred on the Board pursuant to Article 12 of the articles of association of the Company (the “Articles”) or the articles of association produced to the 2023 Annual General Meeting as the new articles of association of the Company (the “New Articles”) (as applicable) to allot or sell Equity Securities (as defined in the Articles or the New Articles (as applicable)), and for that purpose, the Authorized Allotment Amount (as defined in the Articles or the New Articles (as applicable)) shall be an aggregate nominal amount of up to ￡6,799,457 and in addition the Authorized Allotment Amount shall be increased by an aggregate nominal amount of up to ￡6,799,457 provided that the Board’s power in respect of such latter amount may only be used in connection with a pre-emptive issue (as defined in the Articles or the New Articles (as applicable)). This authority shall, unless previously revoked or varied, expire at the conclusion of the Company’s next Annual General Meeting (or, if earlier, at the close of business on the date which is 15 months after the date of the passing of this Resolution) save that the Board may, before such expiry, make offers or agreements (whether or not conditional) within the terms of this authority which would or might require Equity Securities to be allotted or sold after such expiry, and the Board may allot or sell Equity Securities pursuant to such offers or agreements as if the authority conferred on them hereby had not expired.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|